Get the Stockscreener App
5.88
2.97%
0.15
Imagenebio Inc stock is traded at $5.88, with a volume of 145.89K.
It is up +2.97% in the last 24 hours and down -0.17% over the past month.
ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that binds specifically to OX40 receptor on activated T cells to block receptor binding to OX40 ligand (OX40L). IMG-007 is being developed to potentially treat multiple autoimmune and inflammatory diseases and disorders. The company operates in a single segment.
See More
Previous Close:
$5.73
Open:
$5.52
24h Volume:
145.89K
Relative Volume:
0.45
Market Cap:
$66.44M
Revenue:
$3.50M
Net Income/Loss:
$-43.07M
P/E Ratio:
-0.911
EPS:
-6.4543
Net Cash Flow:
$-47.84M
1W Performance:
+29.10%
1M Performance:
-0.17%
6M Performance:
-22.67%
1Y Performance:
+0.00%
1-Day Range:
$5.52
$6.15
1-Week Range:
$4.51
$6.64
52-Week Range:
$3.94
$17.96
Imagenebio Inc Stock (IMA) Company Profile
Name
Imagenebio Inc
Sector
Industry
Phone
857-343-8292
Address
12526 HIGH BLUFF DRIVE, SAN DIEGO
Compare IMA vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IMA
Imagenebio Inc
|
5.94 | 64.09M | 3.50M | -43.07M | -47.84M | -6.4543 |
VRTX
Vertex Pharmaceuticals Inc
|
440.22 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
747.20 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
841.41 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
335.38 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
316.11 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Imagenebio Inc Stock (IMA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-25-25 | Resumed | Wedbush | Underperform |
| Oct-24-25 | Initiated | Leerink Partners | Outperform |
Imagenebio Inc Stock (IMA) Latest News
ImageneBio stock jumps on $30M financing - MSN
ImageneBio $30 million private placement ignites stock - MSN
IMA stock surges 24%, breaks 50-DMA for first time since February – what's driving the rally? - MSN
12 Health Care Stocks Moving In Monday's Intraday Session - Sahm
Morning Market Movers: AVNS, SANA, CRDO, BE See Big Swings - RTTNews
IMA Stock Surges 24%, Breaks 50-DMA For First Time Since February – What's Driving The Rally? - Stocktwits
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
ImageneBio raises $30M to advance alopecia, dermatitis drug By Investing.com - Investing.com Australia
ABDE Stock Poised For Best Rally In Over A Year — What’s Michael Burry Got To Do With It? - Stocktwits
ImageneBio $30 Million Private Placement Ignites Stock - Benzinga
ENDRA Life Sciences (NASDAQ: NDRA) Targets Billions With TAEUS Registered Liver Imaging Technology - openPR.com
ENDRA Life Sciences (NASDAQ: NDRA) Targets Billions With TAEUS® Liver Imaging Technology - Carroll County Mirror-Democrat
ImageneBio, Inc. Enters Securities Purchase Agreement for Private Placement to Support Drug Development (April 2026) - Minichart
IMA Stock Holds Support As Traders Track Cash-Fueled Runway - StocksToTrade
IMA Stock Holds Range As Traders Weigh Cash Burn - timothysykes.com
Morning Market Movers: ALLO, RECT, RVMD, SKYQ See Big Swings - RTTNews
ImageneBio (NASDAQ: IMA) registers 2,508,337 shares; $30M warrant placement - Stock Titan
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
ImageneBio Announces $30 Million Private Warrant Financing - TipRanks
ImageneBio, Inc. Secures $30 Million in Private Placement Led by Coastlands Capital to Advance IMG-007 Development - Quiver Quantitative
ImageneBio (NASDAQ: IMA) secures $30M via pre-funded warrant private placement - Stock Titan
ImageneBio Announces $30 Million Private Placement - Bitget
ImageneBio files to sell 2.51M shares of common stock for holders - MSN
ImageneBio, Inc. announced that it expects to receive $29.999972 million in funding - marketscreener.com
Discount grocery chain Lidl to open its first pub - CNN
Stock List: Research Stocks from Around the World - GuruFocus
ImageneBio (NASDAQ:IMA) Stock Price Down 8.5%Here's Why - MarketBeat
[EFFECT] ImageneBio, Inc. SEC Filing - Stock Titan
IMA Technical Analysis & Stock Price Forecast - Intellectia AI
KZR PE Ratio & Valuation, Is KZR Overvalued - Intellectia AI
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
IMA,CVRX Volatility & Greeks - Finviz
Morning Market Movers: ELAB, EEIQ, VRDN, ASTC See Big Swings - RTTNews
Oil prices rise after Trump issues ultimatum and Iran threatens to close the Strait of Hormuz indefinitely - CNN
IMA,CVRX Dividends - Finviz
ImageneBio (IMA) CEO receives 128,100 options and 85,400 RSUs - Stock Titan
ImageneBio Announces Leadership Transition in Finance Organization - The Globe and Mail
ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
ImageneBio Approves Inducement Grants for New Employees Under Nasdaq Rule 5635(c)(4) - geneonline.com
ImageneBio, Inc. Announces Principal Accounting Officer Changes, Effective March 20, 2026 - marketscreener.com
ImageneBio (NASDAQ: IMA) names Bob Lally Principal Accounting Officer as Erin Butler departs - Stock Titan
Two new ImageneBio hires get four-year stock incentive grants - Stock Titan
Atlas Venture Buys Stake in Biotech Firm ImageneBio - National Today
Atlas Venture Life Science Advisors LLC Buys New Position in ImageneBio, Inc. $IMA - Defense World
Imagenebio Inc Stock (IMA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Imagenebio Inc Stock (IMA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Bonita David P | Director |
Jul 25 '25 |
Buy |
29.90 |
83,611 |
2,499,969 |
287,885 |
| Stampacchia Otello | Director |
Jul 25 '25 |
Buy |
29.90 |
267,556 |
7,999,924 |
454,982 |
1.84%
0.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):